Sign in to add mentor
Michael Derek Waterfield grad student 1986 Imperial College London
 (The structure and function of the receptor for epidermal growth factor)
Robert A. Weinberg post-doc 1986-1989 MIT


Sign in to add trainee
Justin R Cross grad student 2000-2006 UCL
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hill W, Lim EL, Weeden CE, et al. (2023) Lung adenocarcinoma promotion by air pollutants. Nature. 616: 159-167
Zecchin D, Moore C, Michailidis F, et al. (2020) Combined targeting of G protein-coupled receptor and EGF receptor signaling overcomes resistance to PI3K pathway inhibitors in PTEN-null triple negative breast cancer. Embo Molecular Medicine. e11987
Rodríguez-Martínez M, Boissiére T, Gonzalez MN, et al. (2020) Evidence That STK19 Is Not an NRAS-dependent Melanoma Driver. Cell. 181: 1395-1405.e11
Wamaitha SE, Grybel KJ, Alanis-Lobato G, et al. (2020) IGF1-mediated human embryonic stem cell self-renewal recapitulates the embryonic niche. Nature Communications. 11: 764
Carné Sd, East P, Moore C, et al. (2020) Abstract B11: RAS orchestrates the increase of interstitial adenosine in lung adenocarcinoma to promote immune evasion Cancer Immunology Research. 8
Jones GG, Rio IBD, Sari S, et al. (2020) Abstract B26: The SHOC2 phosphatase complex as a therapeutic target for ERK-pathway inhibition in RAS-driven tumors Molecular Cancer Research. 18
Baer R, Rosewell I, Hancock D, et al. (2020) Abstract B19: New tools to study the role of RAS/CRAF interaction in RAS-driven lung cancer Molecular Cancer Research. 18
Molina-Arcas M, Moore C, Rana S, et al. (2019) Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer. Science Translational Medicine. 11
Lionarons DA, Hancock DC, Rana S, et al. (2019) RAC1 Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance. Cancer Cell
Liu H, Ertay A, Peng P, et al. (2019) SGLT1 is required for the survival of triple negative breast cancer cells via potentiation of EGFR activity. Molecular Oncology
See more...